Free Trial

Addus HomeCare (ADUS) Competitors

Addus HomeCare logo
$108.22 -1.21 (-1.11%)
As of 01:08 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ADUS vs. GH, OPCH, RDNT, BTSG, SHC, SGRY, PRVA, CON, WGS, and VCYT

Should you be buying Addus HomeCare stock or one of its competitors? The main competitors of Addus HomeCare include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), GeneDx (WGS), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.

Addus HomeCare vs. Its Competitors

Guardant Health (NASDAQ:GH) and Addus HomeCare (NASDAQ:ADUS) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

Guardant Health presently has a consensus target price of $53.76, indicating a potential upside of 12.32%. Addus HomeCare has a consensus target price of $142.57, indicating a potential upside of 31.74%. Given Addus HomeCare's stronger consensus rating and higher probable upside, analysts clearly believe Addus HomeCare is more favorable than Guardant Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Guardant Health
0 Sell rating(s)
0 Hold rating(s)
21 Buy rating(s)
1 Strong Buy rating(s)
3.05
Addus HomeCare
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.25

Guardant Health has a beta of 1.44, meaning that its share price is 44% more volatile than the S&P 500. Comparatively, Addus HomeCare has a beta of 0.81, meaning that its share price is 19% less volatile than the S&P 500.

92.6% of Guardant Health shares are held by institutional investors. Comparatively, 95.3% of Addus HomeCare shares are held by institutional investors. 6.1% of Guardant Health shares are held by insiders. Comparatively, 4.6% of Addus HomeCare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Addus HomeCare has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Guardant Health$739.02M8.02-$436.37M-$3.39-14.12
Addus HomeCare$1.21B1.64$73.60M$4.4324.43

Addus HomeCare has a net margin of 6.52% compared to Guardant Health's net margin of -53.82%. Addus HomeCare's return on equity of 9.23% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Guardant Health-53.82% N/A -26.77%
Addus HomeCare 6.52%9.23%6.96%

In the previous week, Guardant Health had 7 more articles in the media than Addus HomeCare. MarketBeat recorded 12 mentions for Guardant Health and 5 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 1.55 beat Guardant Health's score of 1.01 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Guardant Health
6 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Addus HomeCare
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

Addus HomeCare beats Guardant Health on 12 of the 17 factors compared between the two stocks.

Get Addus HomeCare News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADUS vs. The Competition

MetricAddus HomeCareMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.99B$4.84B$5.56B$9.30B
Dividend YieldN/A1.34%4.23%4.03%
P/E Ratio24.4334.7028.6119.64
Price / Sales1.6491.64437.49188.30
Price / Cash20.7323.1436.0257.93
Price / Book2.024.268.185.63
Net Income$73.60M$189.47M$3.23B$257.73M
7 Day Performance-5.41%-2.65%-0.25%0.07%
1 Month Performance-5.44%-7.74%5.40%8.32%
1 Year Performance-11.89%-5.46%26.35%13.78%

Addus HomeCare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADUS
Addus HomeCare
4.97 of 5 stars
$108.22
-1.1%
$142.57
+31.7%
-9.1%$1.99B$1.21B24.4349,703Positive News
Analyst Forecast
GH
Guardant Health
4.4857 of 5 stars
$49.54
-1.9%
$53.76
+8.5%
+52.5%$6.26B$739.02M-14.612,021Positive News
Analyst Upgrade
OPCH
Option Care Health
4.4948 of 5 stars
$30.91
-0.8%
$35.50
+14.8%
+2.1%$5.10B$5.00B22.758,088Positive News
RDNT
RadNet
3.4172 of 5 stars
$55.26
-1.7%
$69.60
+26.0%
-11.5%$4.22B$1.83B-128.5111,021
BTSG
BrightSpring Health Services
1.7401 of 5 stars
$22.00
-0.5%
$24.90
+13.2%
+77.2%$3.89B$11.27B78.5735,000
SHC
Sotera Health
3.1954 of 5 stars
$11.40
-2.9%
$16.00
+40.4%
-6.9%$3.33B$1.10B18.943,000News Coverage
SGRY
Surgery Partners
2.5019 of 5 stars
$22.03
-0.5%
$33.56
+52.3%
-15.2%$2.84B$3.11B36.9215,000
PRVA
Privia Health Group
3.8083 of 5 stars
$21.35
-3.4%
$27.77
+30.1%
+14.9%$2.70B$1.74B184.251,140
CON
Concentra Group Holdings Parent
2.8248 of 5 stars
$20.33
-1.1%
$28.50
+40.2%
N/A$2.64B$1.90B15.1711,250
WGS
GeneDx
3.7738 of 5 stars
$85.74
-6.4%
$90.13
+5.1%
+136.8%$2.61B$305.45M100.671,200Analyst Downgrade
VCYT
Veracyte
3.5633 of 5 stars
$26.34
-4.3%
$40.90
+55.3%
+11.7%$2.15B$445.76M30.23790News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:ADUS) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners